INFevo Raises Over RMB 100M Pre-A to Expand AI Virtual-Cell Research

INFevo announced on November 16, 2026 that it had raised more than RMB 100 million in Pre-A funding to expand its AI virtual-cell models and automated experimental systems, according to investor Xinglian Capital’s announcement. The proceeds will also support deeper collaboration with pharmaceutical companies, hospitals and research institutions. Xinglian Capital, Prosperity7 Ventures, Huagai Capital, Huakong Fund and DT Capital joined the round. Existing investors Shunwei Capital, HSG and…

This article has been indexed from Unite.AI